IP Library Granted Patent US 11,071,878
Granted Patent B2
US 11,071,878 · App. 15/924,331 · Granted Jul 27, 2021

Core stabilized microcapsules, method of their preparation and uses thereof

Inventors: Ofer Toledano (Kfar Saba, IL); Haim Bar-Simantov (Netanya, IL); Hanan Sertchook (Gedera, IL); Sharon Fireman-Shoresh (Tel Aviv, IL); Dorit Marco (Rehovat, IL)
Assignee: Sol-Gel Technologies Ltd.
A61Q19/00A61K8/11A61K8/25A61K8/26A61K8/38A61K8/671A61K9/0014A61K9/06A61K9/10A61K9/501A61K9/5115A61K9/5192B01J13/14B01J13/18F28D20/023A61K9/5026A61K47/32A61K47/38A61K2800/412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,878
App. No.
15/924,331
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.

Claims (13)

1. A process for preparing microcapsules having a core encapsulated within an inorganic oxide shell, wherein said core comprises at least one active agent and at least one phase changing material, said process comprising:

(a) preparing an oil-in-water emulsion by emulsification of an oily phase comprising at least one active agent, at least one phase changing material and a sol-gel precursor, in an aqueous phase, wherein said aqueous phase comprises at least one inorganic metal salt;

(b) adjusting the pH of the emulsion to be in the range of 3 to 5; and

(c) subjecting said emulsion to microcapsule forming conditions; thereby obtaining said microcapsules;

wherein said at least one phase changing material is not liquid at room temperature, and wherein said core has a viscosity of from about 300 cP to about 1,000,000 cP.

2. The process according to claim 1 wherein said at least one active agent is selected from the group consisting of a pharmaceutical agent, a cosmetic agent and a dermatological agent.

3. The process according to claim 1 , wherein said at least one active agent is a dermatological agent selected from the group consisting of anti-fungal agents, anti-bacterial agents, anti-inflammatory agents, antipruritic agents, anti-psoriatic agents, anti-acne agents, anti-rosacea agents, and any combinations thereof.

4. The process according to claim 1 , wherein said at least one active agent is an anti-acne agent selected from the group consisting of benzoyl peroxide, retinoid, and mixtures thereof.

5. The process according to claim 1 , further comprising adding at least one inorganic oxide nanoparticle to said aqueous phase prior, during or after preparation of oil-in-water emulsion of step (a).

6. The process according to claim 1 , further comprising adding an inorganic oxide salt to said aqueous phase prior, during or after emulsification of step (a).

7. The process according to claim 1 , wherein said oily phase comprises a sol-gel precursor.

8. Microcapsules obtained by the process according to claim 1 .

9. The process according to claim 1 , wherein said phase changing material is selected from the group consisting of natural or synthetic paraffins, waxes, C 10 -C 100 alkane, C 10 -C 100 alkene, C 10 -C 100 alkyne, aliphatic alcohols, aliphatic fatty acids, and any combination thereof, wherein said aliphatic fatty acid has a molecular formula of CH 3 (CH 2 ) n COOH, and wherein n=10-100.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2025
From: SOL-GEL TECHNOLOGIES LTD.
To: MAYNE PHARMA LLC
Reel/Frame 071148/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2019
From: TOLEDANO, OFER; BAR-SIMANTOV, HAIM; SERTCHOOK, HANAN; FIREMAN-SHORESH, SHARON; MARCO, DORIT
To: SOL-GEL TECHNOLOGIES LTD.
Reel/Frame 050020/0285 →
Continuity (4)
Continuation In Part 15834805 · Dec 7, 2017
Division 13500937
Provisional Application 61291594 · Dec 31, 2009
Related Publication 20180207451A1 · Jul 26, 2018
Cited By (3)
US 12,201,956 US 12,295,935 US 12,491,487